Abstract: A pharmaceutical composition in the form of a chewable tablet for the suppression of gastric reflux comprising an alginic acid or salt thereof, a water-soluble carbonate radical precursor, a calcium salt, a first bulk sweetener, and a binding agent. The calcium salt and either or both of the bulk sweetener and the binding agent may be blended via any of wet granulation, spray drying, or compression processes prior to admixture with the alginic acid and the carbonate radical precursor.

Abstract: A method for managing testing of test material is disclosed. An electronic traveler associated with the test material is identified. The test materials are tested as specified by the electronic traveler. Test results from the tests are recorded onto the electronic traveler.

Abstract: A method is provided for forming a roofing product. The method includes printing an image representing multiple shingles, multiple roofing tiles and/or multiple wood shakes on a face layer. The face layer and a scrim are combined to form a continuous sheet. The face layer is also embossed. Another method also includes combining a face layer and a scrim to form continuous sheet. A transparent and/or translucent film is provided. An image of multiple shingles, multiple roofing tiles and/or multiple wood shakes is printed on a first side of the film. The first side of the film is laminated to the face layer, opposite the scrim. A method of installation of a roofing product is also provided.

Abstract: A cleanser composition suitable for use with oral appliances, which provides a sensory signal to the user. The sensory signal is such that the user believes the signal to indicate that cleasing of the oral device if occurring or, alternatively, that cleansing action has ceased.

Abstract: Denture adhesive solvent compositions comprising at least one oil based solvent, a thickener and a surfactant suitable for removing denture adhesive and adhesive residue from the denture and hard and soft tissues of the oral cavity and denture adhesive removal systems comprising a wipe comprising a flexible substrate premoistened with a denture adhesive solvent composition are disclosed.

Abstract: The invented product is a fleecebacked laminate that is suitable as a single-ply fleecebacked roofing membrane. The laminate consists of the following: 1) a thermoplastic reinforced planar sheet, 2) a needle punched fleece formed on both sides of the thermoplastic reinforced planar sheet, and 3) a thermoplastic polymeric layer extruded onto one side of the fleece. The fleece is formed by needle punching fibers through the reinforced planar sheet. The reinforced planar sheet serves as a common supporting base the resulting two-side fleece. The thermoplastic polymeric layer is embedded with one side of the fleece fibers. The thermoplastic polymeric layer serves as the top layer of the roofing membrane, and the second side of exposed fleece serves as a felt. The thermoplastic polymeric layer is preferably comprised of an extruded PVC substrate, compounded to have excellent weather resistance, printability and to be nonflammable. The fleece fibers are preferably composed of polyester.

Abstract: The invented product is a fleecebacked laminate that is suitable as a single-ply fleecebacked roofing membrane. The laminate consists of the following: 1) a thermoplastic reinforced planar sheet, 2) a needle punched fleece formed on both sides of the thermoplastic reinforced planar sheet, and 3) a thermoplastic polymeric layer extruded onto one side of the fleece. The fleece is formed by needle punching fibers through the reinforced planar sheet. The reinforced planar sheet serves as a common supporting base the resulting two-side fleece. The thermoplastic polymeric layer is embedded with one side of the fleece fibers. The thermoplastic polymeric layer serves as the top layer of the roofing membrane, and the second side of exposed fleece serves as a felt. The thermoplastic polymeric layer is preferably comprised of an extruded PVC substrate, compounded to have excellent weather resistance, printability and to be nonflammable. The fleece fibers are preferably composed of polyester.

Abstract: A pharmaceutical composition in the form of a chewable tablet for the suppression of gastric reflux comprising an alginic acid or salt thereof, a water-soluble carbonate radical precursor, a calcium salt, a first bulk sweetener, and a binding agent. The calcium salt and either or both of the bulk sweetener and the binding agent may be blended via any of wet granulation, spray drying, or compression processes prior to admixture with the alginic acid and the carbonate radical precursor.

Abstract: The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has a methylcellulose, a diluent, a disintegrating agent, and a binding agent. The diluent, the disintegrating agent, and the binding agent are separate ingredients. There is also a process for treating constipation in a human.

Abstract: The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has methylcellulose, a diluent, and a crosprovidone. There is also a process for treating constipation in a human.

Abstract: The present invention relates to a process for preparing a tablet formation. The process has the steps of granulating a methylcellulose, granulating a diluent, and blending the granulated methylcellulose and the granulated diluent to form an intragranulated tablet formation.

Abstract: The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has a methylcellulose, a diluent, and a disintegrating agent. The diluent and the disintegrating agent are separate ingredients. There is also a process for treating constipation in a human.

Abstract: The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has a first phase and a second phase blended with the first phase. The first phase has a compacted mixture of methylcellulose having a viscosity of >1000 centipoise and a diluent. The methylcellulose is the sole active ingredient in the first phase. There is also a process for preparing a rapidly disintegrating tablet.

Abstract: The present invention relates to a single-dose laxative tablet having an intragranular methylcellulose, an intragranular disintegrating agent, and a diluent. The methylcellulose is present in an amount between about 500 mg and 1000 mg and a viscosity of >1000 centipoise. There is also a plurality of tablets for oral administration. There is also a process for treating constipation in a human.